European Medical Solutions.

As of June 30, 2026, European Medical Solutions. carries a market capitalization of 21.16M, placing it among publicly traded companies globally. Its enterprise value stands at 37.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, European Medical Solutions. has 4.23M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, European Medical Solutions. maintains a current ratio of 1.71, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, European Medical Solutions.'s stock has declined approximately 26.80% over the past 52 weeks. The 50-day moving average sits at 3.86, while the 200-day moving average is 4.72.

As of June 30, 2026, European Medical Solutions. holds 3.35M in cash and equivalents against 19.97M in total debt, resulting in a net debt position of 13.37M. Total book value stands at 13.15M, with working capital of 14.50M providing operational flexibility.

European Medical Solutions.'s most recent stock split took place on December 27, 2024 with a 352:1 split ratio.